molidustat
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The present studies assessed the drug–drug interaction of molidustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor…
Introduction New medications for anaemia associated with chronic kidney disease (CKD) are desirable, owing to the limitations of…
BACKGROUND
The recent development of drugs that stabilize HIFalpha, called HIF stabilizers, offers a new strategy for treating…
Background: Approximately 40% of AML patients with IDH1 mutation respond to monotherapy with the IDH1 inhibitor ivosidenib with a…
The development of new therapeutics potentially exhibiting performance-enhancing properties implicates the risk of their misuse…